Volume 7, Issue 5 (Sep & Oct 2017)
J Research Health 2017, 7(5): 979-980 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shahbazzadegan S, Pishvaei M. Cervical cancer vaccine as a priority of public health practices in Iran. J Research Health 2017; 7 (5) :979-980
URL: http://jrh.gmu.ac.ir/article-1-1433-en.html
URL: http://jrh.gmu.ac.ir/article-1-1433-en.html
1- Department of Reproductive health and Midwifery, School of Nursing and Midwifery, Ardabil University of Medical Sciences, Ardabil, Iran
2- Social Development & Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad,Iran ,M Pishvaei
2- Social Development & Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad,Iran ,
Abstract: (4546 Views)
Cervical cancer is the third most common cancer in women. In poor countries, it is the second cause of cancer death [1]. According to official report of World Health Organization, about 500,000 new cases of cervical cancer were recorded each year that more than half of them are leading to death. 80 percent of new cases are occurred in developing countries [2].
Type of Study: Letter to Editor |
Subject:
● Psychosocial Health
Received: 2017/07/8 | Accepted: 2017/08/28 | Published: 2017/08/28
Received: 2017/07/8 | Accepted: 2017/08/28 | Published: 2017/08/28
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
